NCT01507363View on ClinicalTrials.gov

Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Postoperative PainPostoperative Sedation
Interventions
DRUG

Gabapentin

Tables with Gabapentin (1300 mg/ day) for 7 days, starting on the day of surgery

DRUG

Gabapentin

Tables with Gabapentin (900 mg/day) for 7 days, starting on the day of surgery

DRUG

Placebo

Placebo tablets for 7 days, starting on the day of surgery

Trial Locations (3)

6700

Dep. of ortopedic surgery, Esbjerg Sygehus, Esbjerg

9000

Dep. of ortopedic surgery, Aalborg Sygehus, Aalborg

Unknown

Dep. of anesthesiology and ortopedic surgery Hvidovre Hospital, Copenhagen

All Listed Sponsors
collaborator

Lundbeck Foundation

OTHER

lead

Hvidovre University Hospital

OTHER

NCT01507363 - Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA) | Biotech Hunter | Biotech Hunter